Inhibit osteoclast activation and differentiation, reduce bone resorption Block osteoclast differentiation signal RANKL/RANK/OPG pathway: AOD 9604 downregulates the expression of RANKL (a key factor in osteoclast differentiation) and upregulates the expression of OPG (a RANKL antagonist), reducing the RANKL/OPG ratio by 50-60% and blocking the differentiation of osteoclast precursors into mature osteoclasts
Network meta-analysis of curative efficacy of different acupuncture methods on obesity combined with insulin resistance
An important factor in ferroptosis is lipid peroxidation, especially of polyunsaturated fatty acids, in which LOX and ACSL4 play essential roles
A review of GLP-1 receptor agonists in type 2 diabetes: A focus on the mechanism of action of once-weekly agents
Larger, standardized studies are needed to confirm these findings
Research Applications Peptide receptor pathway studies Metabolic research models Laboratory-based compound analysis Stability and formulation testing Explore Related Research Compounds Researchers often explore complementary compounds such as GHK-Cu, NAD+, and GH-3 Complex for broader laboratory studies
